Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_028312929.1 H566_RS0120655 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000482785.1:WP_028312929.1 Length = 422 Score = 416 bits (1068), Expect = e-121 Identities = 240/413 (58%), Positives = 284/413 (68%), Gaps = 28/413 (6%) Query: 4 LGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLD 63 LGT L P+ATRVMLLGSGELGKEV I QRLGVE IAVDRY +AP VAHR+H I M + Sbjct: 5 LGTPLSPSATRVMLLGSGELGKEVLIALQRLGVETIAVDRYDNAPGHQVAHRAHTIAMTN 64 Query: 64 GDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEG-LNVVPCARATKLTMNREGIRRLAA 122 G L+ ++E EKP +VPEIEAIAT ML +LE G + VVP ARA +LTM+REGIRRLAA Sbjct: 65 GAQLKALIEAEKPDLVVPEIEAIATPMLQELEAAGVVRVVPNARAARLTMDREGIRRLAA 124 Query: 123 EELQLPTSTYRFADSESLFREAV-ADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYA 181 E L LPTS Y FAD+ + A+ IGYPC+VKPVMSSSGKGQ+ + + + +AW+YA Sbjct: 125 ETLGLPTSPYAFADTLEQLQAAIDGGIGYPCMVKPVMSSSGKGQSKLDGPDDVKKAWEYA 184 Query: 182 QQGGRAGAGRVIVEGVVKFDFEITLLTV-----SAVDG----------------VHFCAP 220 Q GGR GAGRVIVEG + FD+EITLLTV AVDG HFC P Sbjct: 185 QAGGRVGAGRVIVEGFIDFDYEITLLTVRAHAAPAVDGADGSTPANTGLTRPIDTHFCEP 244 Query: 221 VGHRQEDGDYRESWQPQQMSPLALERAQEIARKVVLAL---GGYGLFGVELFVCGDEVIF 277 +GH Q GDY ESWQP M+PLAL+RAQ+IAR V AL GG G++GVELFV GD V F Sbjct: 245 IGHVQVHGDYVESWQPCAMAPLALQRAQDIARAVTAALGGDGGCGIYGVELFVKGDAVWF 304 Query: 278 SEVSPRPHDTGMVTLISQDLSEFALHVRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTF 337 SEVSPRPHDTG+VTL++Q +EF LH RA LGLPV + P ASAVI + ++ + F Sbjct: 305 SEVSPRPHDTGLVTLVTQWQNEFELHARAILGLPVDTSLR-SPGASAVIYGGVEAKEIVF 363 Query: 338 DNVQNAVGA-DLQIRLFGKPEIDGSRRLGVALATAESVVDAIERAKHAAGQVK 389 D V A+ ++RLFGKPE RR+GVALA A +V A AK AA VK Sbjct: 364 DGVAEALAVPGTELRLFGKPESFVRRRMGVALAHATAVEAARINAKTAASHVK 416 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 515 Number of extensions: 28 Number of successful extensions: 7 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 422 Length adjustment: 31 Effective length of query: 361 Effective length of database: 391 Effective search space: 141151 Effective search space used: 141151 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory